Literature DB >> 32948956

Trends in Industry Payments to Physicians for Antihyperglycemic Therapies Between 2014 and 2018.

Kosuke Inoue1, O Kenrik Duru2, Carol M Mangione2,3, Yusuke Tsugawa2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32948956      PMCID： PMC8342665          DOI： 10.1007/s11606-020-06215-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  7 in total

1.  Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Authors:  Søren L Kristensen; Rasmus Rørth; Pardeep S Jhund; Kieran F Docherty; Naveed Sattar; David Preiss; Lars Køber; Mark C Petrie; John J V McMurray
Journal:  Lancet Diabetes Endocrinol       Date:  2019-08-14       Impact factor: 32.069

2.  Industry Payments and Physician Prescribing.

Authors:  Robert Steinbrook
Journal:  JAMA Intern Med       Date:  2019-10-01       Impact factor: 21.873

3.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Authors:  Thomas A Zelniker; Stephen D Wiviott; Itamar Raz; Kyungah Im; Erica L Goodrich; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Remo H M Furtado; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc S Sabatine
Journal:  Lancet       Date:  2018-11-10       Impact factor: 79.321

Review 4.  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

5.  The U.S. Insulin Crisis - Rationing a Lifesaving Medication Discovered in the 1920s.

Authors:  Michael Fralick; Aaron S Kesselheim
Journal:  N Engl J Med       Date:  2019-11-07       Impact factor: 91.245

6.  Trends in Aggregate Use and Associated Expenditures of Antihyperglycemic Therapies Among US Medicare Beneficiaries Between 2012 and 2017.

Authors:  Andrew Sumarsono; Brendan M Everett; Darren K McGuire; Gregg C Fonarow; Javed Butler; Ambarish Pandey; Muthiah Vaduganathan
Journal:  JAMA Intern Med       Date:  2020-01-01       Impact factor: 21.873

7.  Conflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitus.

Authors:  Susan L Norris; Haley K Holmer; Lauren A Ogden; Brittany U Burda; Rongwei Fu
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240
  7 in total
  1 in total

1.  Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching.

Authors:  Kosuke Inoue; Yusuke Tsugawa; Carol M Mangione; O Kenrik Duru
Journal:  PLoS Med       Date:  2021-06-01       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.